H. Le Guillou-Guillemette

发表

Does Epoetin Beta Still Have a Place in Peginterferon Alpha-2a Plus Ribavirin Treatment Strategies for Chronic Hepatitis C?

N. Picard, D. Larrey, P. Saulnier, 2016, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

IL-26 is overexpressed in chronically HCV-infected patients and enhances TRAIL-mediated cytotoxicity and interferon production by human NK cells

P. Roingeard, C. Créminon, H. Fickenscher, 2014, Gut.

Comparison of performance between three SARS‐CoV‐2 molecular assays (Aptima™, Laboratory Developed Test‐Fusion, and R‐GENE®) with special attention to turnaround time, a key point in laboratory management

C. Lefeuvre, F. Lunel-Fabiani, H. Le Guillou-Guillemette, 2022, Journal of medical virology.

Correlation between the promoter basal core and precore mutations and HBsAg quantification in French blood donors infected with hepatitis B virus

S. Laperche, A. Servant-Delmas, F. Lunel-Fabiani, 2015, Journal of medical virology.

Evaluation of the Aptima™ HBV Quant Dx assay for semi-quantitative HBV viral load from dried blood spots.

C. Lefeuvre, F. Lunel-Fabiani, H. Le Guillou-Guillemette, 2020, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

NS3 Protease Polymorphism and Natural Resistance to Protease Inhibitors in French Patients Infected with HCV Genotypes 1–5

J. Izopet, P. Colson, P. Trimoulet, 2011, Antiviral therapy.

First report of transmission of a highly resistant strain of HIV-1 group O.

L. Meyer, J. Plantier, T. Mourez, 2016, AIDS.

Fatal Myopericarditis Following an Influenza A (H3N2) Infection

S. Behillil, V. Enouf, C. Lefeuvre, 2018, The American journal of case reports.

Resolution of chronic hepatitis Delta after 1 year of combined therapy with pegylated interferon, tenofovir and emtricitabine.

P. Calès, F. Lunel, F. Le Gal, 2010, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

What is the true place of the SARS‐CoV‐2 rapid point‐of‐care antigen test in the hospital setting? Lessons learned from real life

D. Savary, C. Lefeuvre, H. Le Guillou-Guillemette, 2021, Journal of medical virology.

High Endemicity and Low Molecular Diversity of Hepatitis B Virus Infections in Pregnant Women in a Rural District of North Cameroon

J. Huraux, F. Lunel-Fabiani, H. Le Guillou-Guillemette, 2013, PloS one.

Naturally occurring substitutions conferring resistance to hepatitis C virus polymerase inhibitors in treatment-naive patients infected with genotypes 1–5

J. Izopet, C. Henquell, M. Dubois, 2008, Antiviral therapy.

Immune restoration under HAART in patients chronically infected with HIV-1: diversity of T, B, and NK immune responses.

F. Lunel, B. Vielle, G. Rénier, 2006, Viral immunology.

No antibody response in acral cutaneous manifestations associated with COVID‐19?

P. Jeannin, A. Croué, H. Le Guillou-Guillemette, 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

Serological diagnosis of secondary syphilis in a Rituximab‐treated patient: an emerging diagnostic challenge?

N. Dupin, C. Lefeuvre, P. Grange, 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

HCV virology and diagnosis.

F. Lunel, H. Le Guillou-Guillemette, A. Ducancelle, 2021, Clinics and research in hepatology and gastroenterology.

Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir: a French national study of raltegravir-experienced HIV-1-infected patients.

V. Calvez, C. Charpentier, C. Delaugerre, 2015, The Journal of antimicrobial chemotherapy.

Analysis of hepatic fibrosis markers in the serum of chronic hepatitis B patients according to basal core promoter/precore mutants

C. Lefeuvre, P. Jeannin, J. Boursier, 2022, Scientific Reports.

Quasispecies evolution in NS5A region of hepatitis C virus genotype 1b during interferon or combined interferon-ribavirin therapy.

F. Lunel, C. Payan, P. Veillon, 2007, World journal of gastroenterology.

Genetic diversity of the hepatitis C virus: impact and issues in the antiviral therapy.

C. Gaudy-Graffin, A. Goudeau, S. Vallet, 2007, World journal of gastroenterology.

Multicenter Quality Control of Hepatitis C Virus Protease Inhibitor Resistance Genotyping

C. Charpentier, J. Pawlotsky, J. Izopet, 2013, Journal of Clinical Microbiology.

Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL: a 2014 French nationwide study

V. Calvez, C. Charpentier, C. Delaugerre, 2017, The Journal of antimicrobial chemotherapy.

A Pleiotropic Role of the Hepatitis B Virus Core Protein in Hepatocarcinogenesis

C. Lefeuvre, H. Le Guillou-Guillemette, A. Ducancelle, 2021, International Journal of Molecular Sciences.

Resistance to integrase inhibitors: a national study in HIV-1-infected treatment-naive and -experienced patients

V. Calvez, C. Charpentier, C. Delaugerre, 2019, The Journal of antimicrobial chemotherapy.

Virus de l’hépatite C, aspects virologiques

H. Le Guillou-Guillemette, V. Apaire-Marchais, Hélène Le Guillou-Guillemette, 2019, Actualités Pharmaceutiques.

Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence?

V. Calvez, C. Charpentier, C. Delaugerre, 2019, The Journal of antimicrobial chemotherapy.

Evolutionary history of hepatitis C virus genotype 5a in France, a multicenter ANRS study.

M. Van Ranst, J. Izopet, D. Roulot, 2011, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Natural non-homologous recombination led to the emergence of a duplicated V3-NS5A region in HCV-1b strains associated with hepatocellular carcinoma

P. André, J. Pawlotsky, J. Izopet, 2017, PloS one.

Identification of a duplicated V3 domain in NS5A associated with cirrhosis and hepatocellular carcinoma in HCV-1b patients.

P. André, J. Pawlotsky, S. Bertrais, 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Detection and quantification of serum or plasma HCV RNA: mini review of commercially available assays.

F. Lunel-Fabiani, H. Le Guillou-Guillemette, 2009, Methods in molecular biology.

Duplication of the V3 domain in hepatitis C virus (1b) NS5A protein: Clonal analysis and physicochemical properties related to hepatocellular carcinoma occurrence.

P. Saliou, J. Trinchet, G. Barbier, 2016, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Transfusion-Transmitted Hepatitis A Virus, France, 2018

A. Roque-Afonso, C. Lefeuvre, H. Le Guillou-Guillemette, 2022, Emerging infectious diseases.

From national HBV and HDV screenings to vaccination and treatment in healthcare workers: The Mauritanian pilot study.

F. Lunel-Fabiani, P. Veillon, H. Le Guillou-Guillemette, 2021, Vaccine.

Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech)

A. Kouatchet, C. Lefeuvre, F. Lunel-Fabiani, 2020, Journal of Clinical Virology.

Home-based urinary HPV DNA testing in women who do not attend cervical cancer screening clinics.

F. Lunel-Fabiani, H. Le Guillou-Guillemette, A. Ducancelle, 2015, The Journal of infection.

Factors associated with the emergence of integrase resistance mutations in patients failing dual or triple integrase inhibitor-based regimens in a French national survey.

V. Calvez, C. Charpentier, P. Bellecave, 2021, The Journal of antimicrobial chemotherapy.

Human Immunodeficiency Virus Type 1 Group O Infection in France: Clinical Features and Immunovirological Response to Antiretrovirals

C. Charpentier, C. Delaugerre, J. Pawlotsky, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Stable prevalence of transmitted drug resistance mutations and increased circulation of non-B subtypes in antiretroviral-naive chronically HIV-infected patients in 2015/2016 in France

V. Calvez, C. Charpentier, J. Izopet, 2019, The Journal of antimicrobial chemotherapy.

Algorithm-Based Prediction of HIV-1 Subtype D Coreceptor Use

J. Izopet, V. Ferré, S. Raymond, 2013, Journal of Clinical Microbiology.

A first experience of transduction for differentiated HepaRG cells using lentiviral technology

D. Durantel, C. Lefeuvre, F. Lemoine, 2019, Scientific Reports.

Practical approach to method verification in plasma and validation in cerebrospinal fluid under accreditation using a flexible scope in molecular virology: setting up the HIV, HBV and HCV Aptima™ Quant Dx assays

Alexandra Ducancelle, Caroline Lefeuvre, Adeline Pivert, 2019, Clinical chemistry and laboratory medicine.

Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen

V. Calvez, C. Charpentier, F. Brun-Vézinet, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Multicenter Quality Control of Hepatitis C Virus Protease Inhibitor Resistance Genotyping

C. Charpentier, J. Pawlotsky, J. Izopet, 2013, Journal of Clinical Microbiology.